Evidence-Based Medicine

Splenomegaly in Children

Splenomegaly in Children

Background

  • The gold standard definition of splenomegaly is based on the weight of the spleen which can only be determined upon its removal from the body.
  • Ultrasound can be useful in determining splenic size in infants and children.
  • The primary functions of the spleen are immune defense and quality control of circulating red cells.
  • The causes of splenomegaly can be divided into several etiologic groups:
    • infection (viral causes most common)
    • hematologic disorders
    • autoimmune disorders and inflammatory causes
    • storage diseases
    • congestive causes
    • nonhematologic malignancy
    • splenic lesions

Evaluation

  • Obtain a complete history and perform a thorough physical examination.
  • Specific techniques such as the Middleton, Castell, and Nixon methods may help detect splenomegaly on physical examination.
  • Consider obtaining initial laboratory testing in children with splenomegaly such as hematologic and biochemical testing, monospot, autoimmune screening, and urine dipstick.
  • The presence of cytoses or cytopenias may help to differentiate the various causes of splenomegaly.
  • Consider additional laboratory testing in select children depending on historical and clinical features.
  • Consider a splenic ultrasound to confirm the spleen size, shape, and features.
  • If after an initial evaluation is performed and no cause for the splenomegaly is identified, consider watchful waiting or more invasive testing as guided by a specialist.

Management

  • Perform emergency management when signs and symptoms of spontaneous splenic rupture occur such as:
    • diffuse abdominal pain, left upper quadrant pain, left shoulder tip pain
    • hemodynamic instability with rising pulse rate and decreasing blood pressure
  • Perform cause-specific management when a diagnosis for the splenomegaly has been identified.

Published: 10-07-2023 Updeted: 10-07-2023

References

  1. Motyckova G, Steensma DP. Why does my patient have lymphadenopathy or splenomegaly? Hematol Oncol Clin North Am. 2012 Apr;26(2):395-408
  2. Brown NF, Marks DJ, Smith PJ, Bloom SL. Splenomegaly. Br J Hosp Med (Lond). 2011 Nov;72(11):M166-9
  3. Pozo AL, Godfrey EM, Bowles KM. Splenomegaly: investigation, diagnosis and management. Blood Rev. 2009 May;23(3):105-11

Related Topics